JCO Global Oncology · 2020 · 17 citations · 34 references
MedicineBiomedical SciencesOncologyGlobal HealthMedical OncologyTranslational MedicineClinical Trial DesignClinical Trial EthicsClinical Trial PhasesClinical Trial Protocol ReviewClinical TrialsClinical Trials In OncologyComparative Clinical TrialsMulticenter Clinical TrialsTranslational Clinical Trial DesignTranslational Trial Design
The process of developing new anticancer therapeutics has been considered by some to be expensive, time consuming, bureaucratic, and, to some extent, inefficient. The coronavirus disease 2019 (COVID-19) pandemic has significantly affected clinical oncology studies and underlined the need to embrace and accelerate long-pending and awaited reforms to cancer clinical trial methodology.<p><p>\n\nThis article highlights the need for optimal use of technology, reduced paperwork and bureaucracy, speedier trial setup, and greater patient centricity in the design and conduct of future clinical and translational cancer studies around the world.
34
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
Melanie Calvert, Derek Kyte, Rebecca Mercieca‐Bebber et al. · JAMA · 2018 · 798 citations · Full text
Why Most Clinical Research Is Not Useful
John P. A. Ioannidis · PLoS Medicine · 2016 · 638 citations · Full text